Compare Stocks: NTRA, THC, TVTX, UNH, MCK, and XLV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MCK McKesson	$859.81 -0.7%	$788.86	$637.00 ▼ $999.00	$100.68B	0.31	940,166 shs	495,026 shs
NTRA Natera	$268.34 -0.5%	$245.48	$131.81 ▼ $288.04	$38.28B	1.51	1.34 million shs	940,037 shs
THC Tenet Healthcare	$253.90 +0.5%	$190.49	$156.71 ▼ $262.68	$21.86B	1.27	1.28 million shs	644,372 shs
TVTX Travere Therapeutics	$56.07 -2.1%	$53.33	$15.03 ▼ $60.10	$5.22B	1.1	2.10 million shs	935,847 shs
UNH UnitedHealth Group	$416.46 -1.2%	$410.86	$234.60 ▼ $461.62	$378.30B	0.62	8.23 million shs	2.01 million shs
XLV Health Care Select Sector SPDR Fund	$163.13 -0.2%	$156.43	$127.96 ▼ $168.53	$42.07B	0.56	12.07 million shs	7.70 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MCK McKesson	-2.60%	+5.13%	+14.48%	+6.36%	+21.31%
NTRA Natera	+6.24%	+1.88%	-0.66%	+30.80%	+91.30%
THC Tenet Healthcare	-1.78%	+26.49%	+35.25%	+42.81%	+57.02%
TVTX Travere Therapeutics	+3.10%	+1.06%	+0.83%	+35.99%	+270.03%
UNH UnitedHealth Group	+0.04%	-0.46%	+1.32%	+13.59%	+58.20%
XLV Health Care Select Sector SPDR Fund	-1.64%	+1.29%	+3.06%	+12.01%	+21.86%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MCK McKesson	$859.81 -0.7%	$788.86	$637.00 ▼ $999.00	$100.68B	0.31	940,166 shs	495,026 shs
NTRA Natera	$268.34 -0.5%	$245.48	$131.81 ▼ $288.04	$38.28B	1.51	1.34 million shs	940,037 shs
THC Tenet Healthcare	$253.90 +0.5%	$190.49	$156.71 ▼ $262.68	$21.86B	1.27	1.28 million shs	644,372 shs
TVTX Travere Therapeutics	$56.07 -2.1%	$53.33	$15.03 ▼ $60.10	$5.22B	1.1	2.10 million shs	935,847 shs
UNH UnitedHealth Group	$416.46 -1.2%	$410.86	$234.60 ▼ $461.62	$378.30B	0.62	8.23 million shs	2.01 million shs
XLV Health Care Select Sector SPDR Fund	$163.13 -0.2%	$156.43	$127.96 ▼ $168.53	$42.07B	0.56	12.07 million shs	7.70 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MCK McKesson	-2.60%	+5.13%	+14.48%	+6.36%	+21.31%
NTRA Natera	+6.24%	+1.88%	-0.66%	+30.80%	+91.30%
THC Tenet Healthcare	-1.78%	+26.49%	+35.25%	+42.81%	+57.02%
TVTX Travere Therapeutics	+3.10%	+1.06%	+0.83%	+35.99%	+270.03%
UNH UnitedHealth Group	+0.04%	-0.46%	+1.32%	+13.59%	+58.20%
XLV Health Care Select Sector SPDR Fund	-1.64%	+1.29%	+3.06%	+12.01%	+21.86%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MCK McKesson	2.82	Moderate Buy	$962.67	11.96% Upside
NTRA Natera	2.82	Moderate Buy	$267.83	-0.19% Downside
THC Tenet Healthcare	2.85	Moderate Buy	$268.50	5.75% Upside
TVTX Travere Therapeutics	2.69	Moderate Buy	$52.58	-6.22% Downside
UNH UnitedHealth Group	2.89	Moderate Buy	$455.92	9.48% Upside
XLV Health Care Select Sector SPDR Fund	2.77	Moderate Buy	$163.00	-0.08% Downside

Current Analyst Ratings Breakdown

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2026	TVTX Travere Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$56.00 ➝ $62.00
7/28/2026	THC Tenet Healthcare	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$305.00
7/28/2026	UNH UnitedHealth Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
7/28/2026	THC Tenet Healthcare	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$270.00 ➝ $290.00
7/28/2026	THC Tenet Healthcare	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$242.00 ➝ $283.00
7/28/2026	THC Tenet Healthcare	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$210.00 ➝ $280.00
7/27/2026	THC Tenet Healthcare	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$285.00
7/27/2026	THC Tenet Healthcare	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$288.00 ➝ $308.00
7/27/2026	THC Tenet Healthcare	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$308.00
7/27/2026	THC Tenet Healthcare	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$254.00 ➝ $274.00
7/27/2026	THC Tenet Healthcare	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$270.00

(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MCK McKesson	$403.43B	0.25	$44.09 per share	19.50	($14.51) per share	-59.26
NTRA Natera	$2.31B	16.66	N/A	N/A	$12.38 per share	21.68
THC Tenet Healthcare	$22.64B	0.97	$27.30 per share	9.30	$76.12 per share	3.34
TVTX Travere Therapeutics	$536.20M	9.72	$0.37 per share	153.42	$1.28 per share	43.81
UNH UnitedHealth Group	$447.57B	0.85	$21.05 per share	19.78	$115.08 per share	3.62
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MCK McKesson	$4.76B	$38.47	22.35	17.21	1.46	1.18%	-345.35%	5.85%	8/5/2026 (Estimated)
NTRA Natera	-$208.16M	-$1.63	N/A	N/A	N/A	-9.05%	-14.74%	-10.27%	8/6/2026 (Estimated)
THC Tenet Healthcare	$1.41B	$25.93	9.79	13.27	0.98	10.27%	26.76%	5.55%	N/A
TVTX Travere Therapeutics	-$25.55M	-$0.23	N/A	31.33	N/A	-4.00%	-26.16%	-3.71%	8/4/2026 (Confirmed)
UNH UnitedHealth Group	$12.06B	$15.54	26.81	18.68	1.46	3.14%	16.53%	5.43%	N/A
XLV Health Care Select Sector SPDR Fund	N/A	N/A	21.15	N/A	N/A	N/A	N/A	N/A	N/A

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	NTRA Natera	-$0.4977	N/A	N/A	N/A	$661.24 million	N/A
8/5/2026	Q1 2027	MCK McKesson	$9.56	N/A	N/A	N/A	$103.88 billion	N/A
8/4/2026	Q2 2026	TVTX Travere Therapeutics	-$0.14	N/A	N/A	N/A	$159.59 million	N/A
7/23/2026	Q2 2026	THC Tenet Healthcare	$4.26	$6.12	+$1.86	$9.84	$5.43 billion	$6.04 billion
7/16/2026	Q2 2026	UNH UnitedHealth Group	$4.94	$6.38	+$1.44	$6.04	$110.81 billion	$112.03 billion
5/7/2026	Q4 2026	MCK McKesson	$11.56	$11.69	+$0.13	$13.71	$101.35 billion	$96.30 billion
5/4/2026	Q1 2026	TVTX Travere Therapeutics	-$0.2420	$0.05	+$0.2920	-$0.40	$136.23 million	$127.20 million
4/30/2026	Q1 2026	THC Tenet Healthcare	$4.21	$4.82	+$0.61	$8.01	$5.39 billion	$5.37 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MCK McKesson	$3.76	0.44%	+13.68%	9.77%	17 Years
NTRA Natera	N/A	N/A	N/A	N/A	N/A
THC Tenet Healthcare	N/A	N/A	N/A	N/A	N/A
TVTX Travere Therapeutics	N/A	N/A	N/A	N/A	N/A
UNH UnitedHealth Group	$9.28	2.23%	+12.57%	59.72%	15 Years
XLV Health Care Select Sector SPDR Fund	$2.53	1.55%	N/A	N/A	N/A

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2026	MCK McKesson	quarterly	$0.94	0.46%	9/1/2026	9/1/2026	10/1/2026
6/3/2026	UNH UnitedHealth Group	quarterly	$2.32	2.26%	6/15/2026	6/15/2026	6/23/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MCK McKesson	N/A	0.85	0.49
NTRA Natera	N/A	2.96	2.83
THC Tenet Healthcare	2.00	1.41	1.35
TVTX Travere Therapeutics	3.16	3.13	3.08
UNH UnitedHealth Group	0.66	0.78	0.80
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MCK McKesson	85.07%
NTRA Natera	99.90%
THC Tenet Healthcare	95.44%
TVTX Travere Therapeutics	N/A
UNH UnitedHealth Group	87.86%
XLV Health Care Select Sector SPDR Fund	N/A

Insider Ownership

Company	Insider Ownership
MCK McKesson	0.06%
NTRA Natera	5.05%
THC Tenet Healthcare	0.97%
TVTX Travere Therapeutics	4.44%
UNH UnitedHealth Group	0.19%
XLV Health Care Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MCK McKesson	43,000	117.08 million	117.01 million	Optionable
NTRA Natera	6,140	143.21 million	135.98 million	Optionable
THC Tenet Healthcare	99,000	86.14 million	85.30 million	Optionable
TVTX Travere Therapeutics	460	92.99 million	88.86 million	Optionable
UNH UnitedHealth Group	390,000	908.14 million	906.42 million	Optionable
XLV Health Care Select Sector SPDR Fund	N/A	257.96 million	N/A	Not Optionable

NTRA, THC, TVTX, UNH, MCK, and XLV Headlines

Recent News About These Companies

Financial Sector ETF Hits Record High on Fintech Gains

July 28 at 1:48 PM | etftrends.comE

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

July 27, 2026 | zacks.com

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

July 27, 2026 | finance.yahoo.com

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

July 26, 2026 | fool.com

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

July 26, 2026 | fool.com

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

July 21, 2026 | theglobeandmail.com

Risk-Wary Family Offices Double Down on Infrastructure

July 21, 2026 | etftrends.comE

XLV: Healthcare Sector On The Mend, But Probably Not For Long

July 18, 2026 | seekingalpha.com

Seeking Alpha’s quant spotlight: Highest and lowest rated healthcare stocks ahead of Q2

July 17, 2026 | msn.com

Drug Pipeline Wins State Street Over on Healthcare

July 14, 2026 | etftrends.comE

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

July 14, 2026 | zacks.com

Q2 Earnings Preview: Tech & Energy Drive Growth Amid Healthcare Headwinds

July 13, 2026 | etftrends.comE

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

July 11, 2026 | fool.com

Not Just Tech: Invest in Innovation With Healthcare

July 9, 2026 | etftrends.comE

Stocks Look Shaky, But This Sector is Booming (Biotech)

July 9, 2026 | zacks.com

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

July 9, 2026 | 247wallst.com

Healthcare breadth hits 15-year high, but XLV’s top holdings remain quant holds

July 8, 2026 | msn.com

4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues

July 8, 2026 | zacks.com

Weak June Jobs Data Likely to Boost These ETF Areas

July 6, 2026 | zacks.com

State Street Health Care ETF Tops Invesco Pharma on Cost and Size

July 4, 2026 | fool.com

These Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)

...

May 18, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NTRA, THC, TVTX, UNH, MCK, and XLV Company Descriptions

McKesson NYSE:MCK

$859.81 -5.70 (-0.66%)

As of 03:45 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Natera NASDAQ:NTRA

$268.34 -1.32 (-0.49%)

As of 03:45 PM Eastern

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.

Tenet Healthcare NYSE:THC

$253.90 +1.17 (+0.46%)

As of 03:45 PM Eastern

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Travere Therapeutics NASDAQ:TVTX

$56.07 -1.21 (-2.11%)

As of 03:45 PM Eastern

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

UnitedHealth Group NYSE:UNH

$416.46 -5.01 (-1.19%)

As of 03:45 PM Eastern

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$163.13 -0.39 (-0.24%)

As of 03:45 PM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Earnings

Compare Dividends

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NTRA, THC, TVTX, UNH, MCK, and XLV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NTRA, THC, TVTX, UNH, MCK, and XLV Company Descriptions

McKesson NYSE:MCK

Natera NASDAQ:NTRA

Tenet Healthcare NYSE:THC

Travere Therapeutics NASDAQ:TVTX

UnitedHealth Group NYSE:UNH

Health Care Select Sector SPDR Fund NYSEARCA:XLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools